Katharine L. Patrick

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T cell depleted Matched Unrelated Donor Haematopoietic Cell Transplantation.

Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T cell depleted Matched Unrelated Donor Haematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: June 16, 2026

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

Journal: Blood advances

Published: May 07, 2026

Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK study.

Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK study.

Journal: British journal of haematology

Published: January 15, 2026

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia

Published: October 06, 2025

The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT.

The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT.

Journal: Bone marrow transplantation

Published: July 29, 2025

Treosulfan-fludarabine-based conditioning was associated with favourable event-free survival and very low risk of endothelial cell dysfunction in paediatric patients with non-malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study.

Treosulfan-fludarabine-based conditioning was associated with favourable event-free survival and very low risk of endothelial cell dysfunction in paediatric patients with non-malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study.

Journal: British journal of haematology

Published: May 23, 2025

Haematopoietic stem cell transplantation for children and young people: is there a role for prehabilitation? A scoping review.

Haematopoietic stem cell transplantation for children and young people: is there a role for prehabilitation? A scoping review.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 22, 2025

Low rates of endothelial cell dysfunction and transplant-related mortality in 537 children receiving fludarabine-treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT group.

Low rates of endothelial cell dysfunction and transplant-related mortality in 537 children receiving fludarabine-treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT group.

Journal: British journal of haematology

Published: March 10, 2025

Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.

Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.

Journal: Haematologica

Published: November 09, 2024

Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the Infectious Diseases Working Party of the EBMT.

Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the Infectious Diseases Working Party of the EBMT.

Journal: Bone marrow transplantation

Published: November 02, 2024

Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials.

Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials.

Journal: British journal of clinical pharmacology

Published: August 13, 2024

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Journal: British journal of haematology

Published: August 05, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026